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Amygdala Connectivity While Viewing Facial Signals of
Aggression
Luca Passamonti, Molly J. Crockett, Annemieke M. Apergis-Schoute, Luke Clark, James B. Rowe,
Andrew J. Calder, and Trevor W. Robbins
Background: Reduced levels of serotonin (5-HT) within prefrontal cortex (PFC)–amygdala circuits have long been implicated in impulsive
aggression. However, whether lowering 5-HT alters the dynamic interplay between the PFC and the amygdala has not been directly tested
in humans. It is known that manipulating 5-HT via acute tryptophan depletion (ATD) causes variable effects on brain responses to a variety
of emotional stimuli, but it remains unclear whether ATD affects functional connectivity in neural networks involved in processing social
signals of aggression (e.g., angry faces).
Methods: Thirty healthy individuals were enrolled in a randomized, double-blind, placebo-controlled ATD study. On each treatment, brain
responses to angry, sad, and neutral faces were measured with functional magnetic resonance imaging. Twomethods (psycho-physiolog-
ical-interaction in ageneral linearmodel anddynamic causalmodeling)wereused toassess the impactofATDon the functional connectivity
between PFC and amygdala.
Results: Data from 19 subjects were available for the final analyses. A whole-brain psycho-physiological-interaction in a general linear
model showed that ATD significantly modulated the connectivity between the amygdala and two PFC regions (ventral anterior cingulate
cortex and ventrolateral PFC) when processing angry vs. neutral and angry vs. sad but not sad vs. neutral faces. Dynamic causal modeling
corroborated and extended these findings by showing that 5-HT depletion reduced the influence of processing angry vs. neutral faces on
circuits within PFC and on PFC–amygdala pathways.
Conclusions: We provide strong support for neurobiological accounts positing that 5-HT significantly influences PFC–amygdala circuits
implicated in aggression and other affective behaviors.
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S erotoninergic abnormalities within prefrontal cortex (PFC)–amygdala circuits are thought to underlie several psychiatricdisorders characterized by emotional dysregulation, includ-
ng aggression (1,2). Two lines of research support this view.
First, low levels of serotonin (5-HT) metabolites in the cerebro-
pinal fluid and blunted responses to serotoninergic drugs have
een reported in aggressive individuals (3–7). Furthermore, 5-HT
anipulations (dietary andpharmacologic) alter aggressive behav-
or in animals, healthy volunteers, and individuals with history of
ggression (8–12). Aggression is also associated with genetic poly-
orphisms affecting the 5-HT system, including the tryptophan
ydroxylase and monoamine oxidase-A (MAO-A) (13,14). These
tudies have pinpointed a specific role for 5-HT in impulsive-reac-
ive aggression (as distinct from instrumental aggression) (7,15,16),
uggesting that 5-HT is fundamental for regulating emotional be-
avior.
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as implicated abnormalities within PFC–amygdala circuits. These
tudies have frequently used angry faces as stimuli because they
re universal signals of threat and tend to evoke hostile feelings in
he beholder, particularly when interpreted as a provocation (17);
onetheless, it is worth noting that experiencing angry feelings is
ifferent from processing angry faces. Heightened amygdala reac-
ivity to angry faces or aggressive acts has been observed in pa-
ients with violent outbursts, including intermittent explosive dis-
rder (IED) and borderline personality disorder (BPD) (18–21), as
ell as in violent offenders (22). Evidence for PFC involvement
omes from patients with lesions of the orbitofrontal cortex (OFC)
ho often display heightened levels of aggression (23) and from
ork showing reduced medial PFC in response to anger induction
n BPD patients and depressed patients with anger attacks (19,24).
owever, some studies have failed to detect hypoactive PFC re-
ponses in aggressive individuals (22), suggesting that PFC abnor-
alities in aggression may be more complex than simple hypoac-
ivity (25); for instance, connectivity between PFC and subcortical
egions may be impaired. There is evidence suggesting that func-
ional interactions between the PFC and amygdala are indeed crit-
cal for processing facial signals of anger.
One study reported reduced functional coupling between
mygdala and OFC when viewing angry faces in patients with IED
nd BPD relative to healthy control subjects (18,26). Another study
n healthy volunteers showed that reward drive, a personality trait
inked to aggression (27–30), predicted reduced connectivity be-
ween the ventral anterior cingulate cortex (vACC) and amygdala
hen processing angry vs. neutral faces (31). Although it has been
uggested that 5-HT plays a role in facilitating functional interac-
ions between PFC and amygdala (1,2), direct evidence for this
ypothesis is limited. Comparative research has shown reduced
BIOL PSYCHIATRY 2012;71:36–43
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L. Passamonti et al. BIOL PSYCHIATRY 2012;71:36–43 37levels of 5-HT within the PFC of aggressive animals (32–35), and a
positron emission tomography study reported reduced metabo-
lism in OFC and ACC in response to a 5-HT challenge in impulsive
aggressive patients (36). However, no study has examined the ef-
fects of manipulating 5-HT on functional connectivity within the
neural networks linked to aggressive behavior yet.
To investigate 5-HT function in humans, researchers frequently
use a dietary procedure called acute tryptophan depletion (ATD)
(37–39). Tryptophan is the chemical precursor of 5-HT and is only
obtained through the diet; hence, ingesting an alimentary mixture
without tryptophan rapidly decreases plasma and brain levels of
5-HT (40–43). In the current study, we used functional magnetic
resonance imaging (fMRI) to explore how ATD influences brain
circuitry involved in processing facial expressions of anger. Because
reward drive strongly influences regions underlying anger process-
ing (31,44–46), we also investigated whether this personality mea-
sure interacted with the effects of ATD on brain function. Although
previous research has examined the effects of ATD on neural re-
sponses to emotional facial expressions (39,47–50) and has shown
that OFC activity during resting state is reduced by 5-HT depletion
(51), the results have been variable; furthermore, no study has spe-
cifically examined the neural responses to angry faces, an ecologi-
cally valid stimulus for probing brain networks involved in reactive
aggression (52).
Wepredicted that ATDwould affect the connectivity among the
amygdala, OFC, vACC, and/or ventrolateral PFC (VLPFC), a set of
tightly interconnected regions rich in 5-HT and involved in control-
ling aggression and, more generally, in emotional regulation (1–
2,53–60). In particular, we hypothesized that the negative change
in connectivity previously detected between the amygdala and
vACC (31), when viewing angry vs. neutral faces, would be altered
(reduced or reverted) by ATD. Formal analyses of the effective con-
nectivity allow heightened understanding of how ATD modulates
the circuitry underlying processing angry faces and of how brain
effects driven by 5-HT manipulation may interact with personality
measures (e.g., reward drive) linked to aggression.
To achieve these objectives, two different but complementary
methods for investigating brain effective connectivity were used:
psycho-physiological-interactions (PPI) in a general linear model
(GLM) and dynamic causal modeling (DCM). PPI-GLM is an anatom-
ically unconstrained (whole-brain), data-driven approach but does
not provide the directionality of any changes in connectivity be-
tween regions (61). DCM is an alternative method for analyzing PPI
within hypothesis-driven models that overcomes this limitation
(62). Specifically, DCM explains the activity of groups of regions in
terms of 1) “driving” inputs (here, processing a face, regardless of
the expression) directly triggering the response in one or more
areas of the network; 2) a psychological context (here, viewing
angry vs. neutral faces) acting on “intrinsic” (anatomic) pathways
and changing the pattern of functional connectivity between re-
gions (62).
Methods andMaterials
Participants
Thirty healthy volunteers (17 women; mean age: 25.1  3.2
years) gave their written informed consent and were financially
compensated for participating in this study that was approved by
the Cambridgeshire Research Ethics Committee. Exclusion criteria
included history of cardiac, hepatic, renal, pulmonary, gastrointes-
tinal, and neurological disorders; medication use; and personal or
family history of major depression, bipolar disorder, or other psy-
chiatric illness. After a screening interview, participants were hssigned to receive either the tryptophan-depleting drink or the
lacebo mixture on the first session in a double-blind, counterbal-
nced order. Participants attended two distinct sessions, sepa-
ated by at least 1 week. At each session, participants completed
self-report measure of the mood state (see Supplement 1) and
he fMRI task (described subsequently). On the first session,
articipants completed a personality questionnaire assessing
he reward drive (27).
erotonin Dietary Manipulation
We used ATD to temporarily lower plasma and brain 5-HT levels
n a randomized, double-blind, placebo-controlled, within-sub-
ects, counterbalanced design, as previously described (63) (Sup-
lement 1). Blood samples were collected at baseline and before
canning to confirm the plasma tryptophan depletion.
MRI Task
Participants categorized the sex of angry, sad, and neutral faces
50% female, 30 identities). Faces were selected from two stimulus
ets (64) (http://www.macbrain.org) on the basis of emotional rat-
ngs from an independent sample (65). Emotional ratings were also
btained from all participants in the study during each treatment
ATD and placebo). Stimuli were grouped in 17.5-sec epochs con-
aining five faces from the same category (angry, sad, neutral) inter-
ixedwith 5 null events (fixation cross). Each face trial comprised a
000-msec presentation of a face followed by a fixation cross (750
sec). Null events constituted a 1750-msec presentation of the
ame fixation cross. Stimuli within each epoch were pseudo-ran-
omizedwith respect to trial type (face or null events), face sex, and
dentity; no more than three consecutive trials were of the same
rial type. Pseudo-randomization enhances design efficiency while
reserving the unpredictability of stimulus onsets in naïve partici-
ants. Therewere 12 epochs for each category (60 angry, 60 sad, 60
eutral faces; total task duration: 10 min, 30 sec) and 2 orders of
resentation, counterbalanced across treatments and subjects. Re-
ction times (RT) and accuracy for gender discriminations were
ecorded throughout the task.
mage Acquisition and Preprocessing
The fMRI was performed on a 3-Tesla Unit (Tim Trio; Siemens,
urrey, England) set at the Wolfson Brain Imaging Centre. Whole-
rain data were acquired with echo-planar imaging (EPI) sensitive
o thebloodoxygenation level–dependent signal contrast (32 axial
lices, 3-mm thickness; repetition time, 2000 msec; echo time, 30
sec; voxel size, 3 3 3 mm; field of view, 192 mm). Data were
nalyzed with SPM8 (http://www.fil.ion.ucl.ac.uk/spm). EPIs were
inc-interpolated in time to adjust for slice time differences and
ealigned to the first scan by rigid body transformations to correct
or headmovements. Themean EPI was computed for each subject
nd visually inspected to check for excessive signal dropout in the
edial temporal cortices and OFC. EPIs were normalized to the T1
tandard template in the Montreal Neurological Institute (MNI)
pace using linear and nonlinear transformations and were
moothedwith a Gaussian kernel of full width at halfmaximumof 8
m.
nalyses of Regional Effects
For each participant, a GLM assessed regionally specific effects
f task parameters on blood oxygenation level–dependent indices
f activation. The first-level model included four experimental fac-
ors (angry, sad, neutral faces, and null events) and six realignment
arameters as effects of no interest to remove residual motion-
elated variance. Low-frequency signal drift was eliminated using a
igh-pass filter (cutoff, 128-sec) and an autoregressive model
www.sobp.org/journal
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w[AR(1)] was applied to correct for voxels’ autocorrelations. Subjects’
specific contrast images were generated for the angry  neutral
comparison and entered into a second-level GLM investigating the
main effect of treatment (ATD placebo, placebo ATD; paired t
ests); similar analyses addressed the main effect of treatment for
ad neutral and angry sad faces comparisons. These random-
ffects analyses assessed effects on the basis of intraparticipant
ariance and allowed inferences about the population that the
articipants were drawn from (66).
Two approaches for thresholding second-level maps were ap-
lied. First, for a priori regions of interest (ROIs), the threshold was
et at p .05, family-wise error (FWE) correction for multiple com-
arisons in small volumes (i.e., small volume correction [svc])
67,68). The amygdala, ACC, insula, VLPFC, andOFCwere defined as
OIs given their fundamental role in aggression and emotional
ehavior in general (1,2). All ROIs were defined using the “aal.02”
tlas for automated anatomic labeling (69). Second, we reported
egions that were not predicted a priori but met a threshold of p
001, uncorrected, greater than 10 contiguous voxels.
ffective Connectivity Analyses
Psychophysiological Interaction in a GLM. The physiologic
onnectivity between two regions can vary with the psychological
ontext (61). In this study, the connectivity arising from the presen-
ation of faces could vary depending on whether the context is
ngry vs. neutral, for example. This constitutes a Psychophysiolog-
cal Interaction (PPI) (61). We sought to identify “target” areas that
ad a differential connectivity with a “source” (amygdala) as a func-
ion of each context and treatment (ATD vs. placebo).
Separate PPIs were carried out for angry vs. neutral, sad vs.
eutral, or angry vs. sad contexts, using either the right or left
mygdala seed. All PPIs used the same procedure, so it is described
or the right amygdala seed and the angry vs. neutral contexts
lone.Data from the amygdalawere extracted froma8-mmsphere,
onstructed around the MNI center of mass derived from the ana-
omical definition of the amygdala according to the aal.02 atlas
right amygdala, x 28, y 0, z –20; left amygdala, x –24, y –2, z –18) (69).
he time series for each participant was computed using the first
igenvariate from all voxels’ time series within the sphere and then
econvolved to estimate a “neuronal time series” (70). The PPI
egressorwas calculated as the element-by-element product of the
ight amygdala neuronal time series and a vector coding for the
ain effect of task (1 for angry, –1 for neutral, 0 for sad faces, 0 for
ull events). This product was reconvolved by the canonical hemo-
ynamic response function (HRF). The first-level model included
hemain effect of the task convolved by theHRF and sixmovement
arameters as effects of no interest. Subject-specific PPI contrast
mages were computed and entered into a second-level GLM that
dentified those brain areas for which the change in connectivity
ith the amygdala (for the angry vs. neutral contrast) was modu-
ated by treatment (ATD vs. placebo; paired t test). We also exam-
ned whether participants’ sex, individual differences in reward
rive or plasma tryptophan levels modulated any ATD effect on
rain connectivity. The same statistical approaches previously de-
cribed for the analyses of regional effects were employed for sec-
nd-level connectivity maps.
DCM. Distinct DCM analyses were conducted for each treat-
ent (ATD, placebo) using the following procedure. Models were
reated on the basis of the neural circuit identified by PPI-GLM (see
PI in Results). Data from the right amygdala, used in PPI-GLM,were
lso employed in DCM. For the right vACC and VLFPC, first eigen-
ariates were extracted from 15-mm spheres centered on the local
axima identified by PPI. The standard model included “intrinsic” 5
ww.sobp.org/journalidirectional connections among the amygdala, vACC, and VLFPC,
ccording with the anatomy of this circuit (55–60). “Intrinsic” con-
ections (DCM matrix “A”) represent the fixed coupling between
egions in absence of any experimentalmanipulation. Responses in
network can be changed in two ways. First, “driving inputs” (all
aces vs. fixation, DCM matrix “C”) can directly influence individual
r groups of regions within the network. Second, changes in the
sychological context (anger vs. neutral faces; DCMmatrix “B”)may
odulate the “intrinsic” connections.
We specified 49 biologically plausiblemodels inwhich the num-
er and location of “driving inputs” and psychological modulators
ystematically varied. As recently described (71), models were
rouped in “Meta-Families” (A,B,C) based onwhere “driving inputs”
ntered thenetwork. These entered the circuit via 3, 2, or 1 region(s)
Meta-Families, A, B, or C, respectively). Each Meta-Family com-
rised three families. This further grouping reflected differences in
he number and location of connections at which angry vs. neutral
odulated bidirectional connections across either 3, 2, or 1 path-
ay(s). Figures S1–S3 in Supplement 1 display all models.
Random-effects Bayesian model selection (RFX-BMS, SPM8/
CM10 toolbox) (72–74) under ATD and placebo identified the
ost likely model. However, the relative model evidences of mod-
ls can be only compared within the same data sets (ATD and
lacebo, separately) and not across treatments. This does not pre-
ent DCM from being used to test pharmacologic effects on brain
etworks, especially where relative model differences are reversed
etween groups or drug conditions, as previously demonstrated
75). RFX-BMS reports the expected posterior probability (how
ikely it is that a specific model generated the data of a randomly
hosen subject) and the exceedance probability (how much each
odel is more likely than any other model). These two values from
FX-BMS are in themselves statistical inferences (statements of rel-
tive probabilities) andnot absolute parameters of the goodness of
odel fit for a data set. RFX-BMS does not assume that the optimal
odel is themost likely for all subjects individually and is therefore
ess susceptible to outliers than fixed-effects methods (72–74). This
mplies thatmodel selection is relativistic, assessingmodels against
ach other. Furthermore, the expected and exceedance probabili-
ies of an individualmodelwill be reduced as the number ofmodels
ncrease. Hence, we only examined a set of highly plausiblemodels
nd grouped those with shared features into Families and Meta-
amilies.
esults
articipants
Eleven subjects (8women)were excluded fromfinal analyses for
t least one of the following reasons: 1) head movements greater
han 2 mm during one or both fMRI sessions; 2) excessive signal
ropout in themedial temporal regions and/or OFC, as assessed by
careful visual inspection of the mean EPI. The final group thus
ncluded 19 subjects (9 women; mean age: 24.5 SD 3.3 years).
erotoninManipulation
ATD significantly reduced both plasma tryptophan levels and
he ratio between tryptophan and other large neutral amino acids
TRP:LNAA). A repeated-measures analysis of variance revealed a
ignificant 2-way interaction between treatment (ATD, placebo)
nd time point (baseline, prescan [5.5 h since baseline]), resulting
rom significant reductions in total tryptophan levels [F (1,18) 
08.5, p .0001) and TRP:LNAA ratio [F (1,18) 28.6, p .0001]
.5 h followingATD relative to placebo (Figure S4 in Supplement 1).
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Paired t tests exploring the main effect of treatment (ATD 
lacebo, placebo ATD) for each contrast (angry neutral, sad
neutral, angry sad) did not identify significant activations in any
rea including our a priori ROIs. For regional effects during placebo
nd ATD separately, see Supplement 1.
ffective Connectivity 1: PPI in the GLM
Despite no effect on local brain activity, self-reported mood,
MRI task performance or ratings of facial expressions (Supplement
), thePPI for the right amygdala seedand for angry vs. neutral faces
nd ATD vs. placebo comparison identified the right vACC and
LPFC (MNI localmaxima, vACC: x 10, y 44, z 2; T 4.1; p .04, FWE,
svc; VLPFC: x 52, y 42, z 2; T 5.0; p .01, FWE, svc, Figure 1C-E). Of
note, thesewere the only two regions in thewhole brain showing a
change in connectivity with the right amygdala as a function of
viewingangry faces andATD.A similar effectwas foundwhenusing
the left amygdala seed, although at a lower threshold (see Supple-
ment 1). Importantly, ATD significantly reverted the negative
change inPFC–amygdala connectivity identifiedunderplacebo (for
angry vs. neutral faces; Figure 1F–1G). Furthermore, these results
were driven by the angry face context, because the PPI for angry vs.
sad produced similar results to those identified for angry vs. neutral
and for both the right and left amygdala seed (see Supplement 1),
whereas no significant effectswere found for the sad vs. neutral PPI.
The investigation of the interaction between treatment and reward
drive demonstrated a significant PPI for the right amygdala seed
and for angry vs. neutral in the vACC (x 8, y 46, z 4, T 4.6, p .05,
Figure 1. (A) Examples of angry and neutral faces during the task. (B)
Source” for Psycho-Physiological Interactions (PPI) (8-mm right amygdala
phere). (C–E) PPI Statistical Parametrical Maps (SPM). These SPM maps
emonstrate that the ventral anterior cingulate cortex (vACC) and the ven-
rolateral prefrontal cortex (VLPFC) are the only two regions in the whole
rain that are connected with the right amygdala as function of viewing
ngry vs. neutral faces and treatment (acute tryptophan depletion [ATD]
nd placebo; paired t tests). Slices shown (x, y, z) are in the Montreal Neuro-
ogical Institute space. For display purposes, threshold is set at p  .001,
ncorrected; the effects are significant at p  .05, family-wise error, small
olume correction. The color bar represents t statistics. R, right hemisphere.
F, G) Plots of the individual data for the local maxima displayed in panels C
ndD, respectively. SignificantdifferencesbetweenplaceboandATD reflect
negative change in the connectivity between the amygdala and vACC/
LPFC during placebo and a positive change in connectivity between them
ame regions during ATD. Black lines represent mean values for each treat-
ent (placebo, ATD).WE, svc; Figure 2A–2B). Individuals with high reward drive dis-
layed the highest magnitude of the ATD effect relative to placebo
Figure 2C). Finally, no brain areas were identified for the opposite
omparison (placebo vs. ATD) for each contrast (angry vs. neutral,
ngry vs. sad, sad vs. neutral). For connectivity effects under pla-
ebo and ATD separately, for the ATD by sex interaction and for the
ffect of plasma tryptophan levels, see Supplement 1.
nalysis of Effective Connectivity 2: DCM
For placebo, RFX-BMS indicated evidence favoring model C1.1
Figure 3B–E). In this family (Figure 3A), driving inputs (all faces)
ntered the system via the amygdala alone, whereas the angry
s. neutral modulator affected bidirectional connections in all
hree pathways. Hence, during placebo, the effect of the task
s distributed within internal PFC circuitry and across PFC–
mygdala connections.
Under ATD, the expected and exceedance probabilities of C1.1
ere reduced (Figure 3C–F) with increased expected and ex-
eedance probabilities of the twomodels (C2.1, C3.1) (Figure 3D) in
hich the contextual modulator acted on two or one bidirectional
onnections. Furthermore, during ATD, another family of six mod-
ls (Figure S3 in Supplement 1) became more likely than under
lacebo, in which driving inputs “perturbed” the network via either
he VLPFC or vACC alone.
To summarize, ATD reduced not only the number of PFC–
mygdala pathways affectedbyprocessing angry faces but also the
ocation where face information entered the network.
iscussion
We demonstrated that ATD significantly altered the functional
onnectivity between the amygdala and right vACC and VLPFC
henprocessingangry comparedwithneutral faces. Additional PPI
nalyses showed that the right amygdala–vACC connectivity was
odulated by individual differences in reward drive, a personality
rait linked to aggression (27–30). DCM supported and extended
hesefindings. Thebest data-fittingmodel underplacebowas char-
cterized by diffuse modulation of angry faces on internal PFC
athways (vACC↔ VLPFC) and on PFC-amygdala reciprocal con-
ections (vACC↔ amygdala, VLPFC↔ amygdala). ATD made this
igure 2. (A, B) The ventral anterior cingulate cortex (vACC) is connected
ith the right amygdala as a function of treatment (acute tryptophandeple-
ion [ATD], placebo) and reward drive (BAS, behavioral activation system;
reatment by personality interaction; for angry vs. neutral faces). Slices (x, y)
re in the Montreal Neurological Institute space. For display purposes,
hreshold is set atp .001, uncorrected; the effects are significant atp .05,
amily-wise error, small volume correction. The color bar represents t statis-
ics. (C)Plot of individual data for the localmaximadisplayed inpanelsA and
. High-BAS-drive individuals displayed the largest effect of ATD on
mygdala-vACC connectivity.odel relatively less likely while enhancing the probability of alter-
www.sobp.org/journal
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wnative models in which angry faces acted on a reduced number of
pathways.
The evidence that ATD altered connectivity within PFC–
amygdala circuits when processing angry faces, particularly in high
reward-drive people, supports neurobiological models positing
that 5-HT facilitates the PFC in suppressing the negative emotions,
generated in theamygdala, that are associatedwith aggressionand
other emotional behaviors (1–2,32,34,76). Although underlying
molecular mechanisms are poorly understood, dysfunctions in
5-HT reuptake (5-HT transporter, 5-HTT), catabolism (MAO-A), and
postsynaptic receptors (5-HT2A and 5-HT2C) are thought to disrupt
PFC top-down control over the amygdala, resulting in emotional
dysregulation (1,77–83). This view is supported by neuroimaging
research demonstrating that genetic polymorphisms of 5-HTT and
MAO-A modulate circuits underlying emotions and impulsivity
(79,81–87). The 5-HTT polymorphism is also known to interact with
ATD in modulating brain metabolic abnormalities in the vACC and
amygdala of patients withmajor depressive disorders (88). Further-
more, selective binding of 5-HTT or 5-HT2A/5-HT2C receptor ago-
nists is changed in the ACC and OFC of individuals with BPD or IED,
two psychiatric conditions characterized by extreme violence
Figure 3. (A) Preferredmodel during placebo. The amygdala (AMY) is the on
“perturbation” of the network. In this model, the contextual modulator (ang
anterior cingulate cortex (vACC), ventrolateral prefrontal cortex (VLPFC), an
between regions irrespective of any experimental manipulation and are m
probability and (E andF)exceedanceprobability for all 49models shown inS
uring placebo and acute tryptophan depletion (ATD). Comparedwith place
he same time, model C2.1 and C3.1 (D) becamemore likely. These latter m
two or one couples of specific pathways) compared with model C1.1 where(89,90). Overall, these results suggest possible mechanisms by t
ww.sobp.org/journalhich ATD may influence PFC–amygdala connectivity and, conse-
uently, aggression and other affective behaviors. However, pru-
ence is warranted when attributing specific molecular mecha-
isms to the ATD effect on functional connectivity because we did
ot measure 5-HTmetabolism or receptor function. Because of the
iffuse cortical–subcortical projectionsof the serotoninergic raphe-
uclei, it could also be that ATD affected PFC–amygdala connectiv-
ty via its effects on single regions; for example, acting on intra-
mygdala inhibitory interneurons (91). However, the lack of ATD
ffects on isolated brain activities does not support this hypothesis.
n contrast, negative regional findings highlight the importance of
ssessing functional connectivity when exploring brain effects of
harmacologic manipulations (92).
Another issue concerns the roles that vACC and VLPFCmay play
n modulating amygdala function. The vACC is a key region in
egulating emotional behavior, given its abundant anatomic links
ith the amygdala andbrainstemnuclei responsible for the visceral
nd endocrine responses associated with salient events (58–60).
n the other hand,widespread connections of the VLPFCwith both
ognitive (e.g., dorsolateral PFC, inferior parietal lobule) and limbic
egions (including vACC and amygdala) allow it to integrate execu-
ionwhere driving inputs (all faces vs. fixation, black “thick” arrows) start the
neutral faces, red arrows) influences all neural pathways linking the ventral
Y. The intrinsic connectivity (black “thin” arrows) represents the couplings
led as reciprocal connections between all three regions. (B, C) Expected
ment1Figures S1–S3using random-effects (RFX) Bayesianmodel selection
nder ATD,model C1.1 has lower expected and exceedance probabilities; at
are characterized by a smaller number of contextual modulators (affecting
extual modulators affect all possible pathways.ly reg
ry vs.
d AM
ode
upple
bo, u
odelsive functions with affective stimuli (93,94). This flow of communi-
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L. Passamonti et al. BIOL PSYCHIATRY 2012;71:36–43 41cation between the amygdala, vACC and VLPFCmay be one way in
which emotions influence cognition and vice versa. ATD signifi-
cantly affected these neural interactions, which might explain the
profound impact of 5-HT manipulations on basic emotional reac-
tions as well as on complex decision-making processes necessitat-
ing an high-level integration of affective and abstract informations
(63,95–98).
It is also noteworthy that during placebo, facial informations
(“driving inputs”) entered the circuit via the amygdala alone, while
under ATD the role of the amygdala was relatively reduced, and
other routes by which faces could activate the network became
more likely (via either the VLPFC or vACC alone). Hence, ATD may
also alter themore fundamental neuralmechanismsbywhich faces
engage the amygdala and PFC regions. There is evidence, from
electrophysiologic studies in humans and cell recordings in mon-
keys, that neurons within the amygdala, vACC, and VLPFC show a
similar fast response (110–220 msec) to faces, although it is un-
known whether the rapid activation of PFC neurons occurs via the
amygdala or is mediated via extra-amygdala pathways (99–102).
FX-BMS strongly supported the first hypothesis under placebo,
ut less so likely under ATD. However, in a prior nonpharmacologic
CM study, we found that facial informations entered both the
mygdala and vACC, suggesting that the vACC response to faces
ay be triggered via extra-amygdala routes (31). Nonetheless, we
id not previously include the VLPFC, and this, along with a larger
odel space selection, may have led to different model selection
cross experiments (72–74).
Questions may arise regarding the absence of effects for sad
aces given that previous ATD fMRI studies have reported both
ignificant (48,50) and nonsignificant findings for this stimulus (39).
ecause the former result may depend on a familial or personal
istory of depression (50), it is worth emphasizing thatwe excluded
ubjects with these histories. Nonetheless, the specificity of our
ndings for angry faces remains tobe verified in future experiments
omparing anger with other emotions as fear, disgust, surprise, or
appiness.
Lastly, it might be argued that our results reflect a global ATD-
ffect on cerebral blood flow rather than specific mechanisms on
rain 5-HT levels, as recently surmised (103). However, this possibil-
ty appears unlikely because we found functional connectivity
hanges that were strikingly restricted to particular PFC areas and
ritically depended on a specific task. A general vascular effect is
nlikely toproduce such regional- and task-distinct results. Further-
ore, although we acknowledge that ATD also triggers additional
olecular mechanisms that are not directly related to 5-HT (103), it
s important tonote that theoverall current evidence is still favoring
predominant ATD effect on serotoninergic function (104).
In conclusion, this research represents a significant advance in
building realistic circuitry models exploring brain effects of sero-
toninergicmanipulation. Thesemodelsmayhave clear implications
for a broad range of psychiatric disorders, including aggression,
that strongly depend on 5-HT dysfunctions.
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